| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.38B | $5.80B | $6.39B |
| YoY Revenue Growth % | -7.2% | -9.3% | — |
| Gross Profit | $2.00B | $2.25B | — |
| Gross Margin % | 37.2% | 38.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $76.5M | $241.5M | $464.6M |
| Operating Margin % | 1.4% | 4.2% | 7.3% |
| Net Income (GAAP) | $133.0M | $251.6M | $411.1M |
| EBITDA (Normalized) | $119.0M | $286.5M | $694.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $320.0M | $410.5M | $636.9M |
| Capital Expenditures (CapEx) | $53.2M | $56.3M | $287.7M |
| Free Cash Flow (FCF) | $266.8M | $354.2M | $349.2M |
| FCF Margin % | 5.0% | 6.1% | 5.5% |
| Return on Invested Capital (ROIC %) | 4.0% | 12.7% | 7.9% |
| Cash & Short-Term Equivalents | $464.4M | $537.6M | — |
| Total Debt (Short + Long Term) | $711.2M | $664.4M | $1.80B |
| Total Stockholders' Equity | $1.28B | $1.38B | $3.68B |